Mirae Asset Global Investments’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-16,277
Closed -$408K 2459
2024
Q1
$408K Sell
16,277
-4,448
-21% -$59.3K ﹤0.01% 1990
2023
Q4
$264K Hold
20,725
﹤0.01% 2246
2023
Q3
$272K Hold
20,725
﹤0.01% 2173
2023
Q2
$530K Buy
20,725
+4,448
+27% +$115K ﹤0.01% 1924
2023
Q1
$410K Buy
16,277
+2,300
+16% +$54K ﹤0.01% 2024
2022
Q4
$321K Hold
13,977
﹤0.01% 2123
2022
Q3
$308K Buy
+13,977
New +$270K ﹤0.01% 2144

Other funds holding TMCI

Mirae Asset Global Investments's TMCI Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of Treace Medical Concepts (TMCI) in Q2 2024, closing a stake of 16,277 shares — an estimated $408K sold.

Mirae Asset Global Investments first reported a position in TMCI in Q3 2022 and held it in 7 quarters. The position peaked at $530K in Q2 2023. 127 funds tracked by Wall St. Rank hold TMCI as of Q2 2024.

  • Mirae Asset Global Investments reported no remaining Treace Medical Concepts position as of Q2 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 16,277 Treace Medical Concepts shares in Q2 2024, an estimated $408K.
  • Mirae Asset Global Investments first reported a position in Treace Medical Concepts in Q3 2022 and held it in 7 quarters.
  • Mirae Asset Global Investments's Treace Medical Concepts position peaked at $530K in Q2 2023.
  • 127 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.